Your session is about to expire
What is Reyataz
Effectiveness
When to interrupt dosage
The proposed dosage of Reyataz is predicated upon the determined condition, including weight of at least 35 kg, Antiretroviral Therapy and HIV (Human Immunodeficiency Virus). The measure of dosage is contingent upon the form of administration (e.g. Tablet, film coated or Oral) featured in the table below.Warnings
Reyataz has nineteen contraindications, and its use should be avoided where any of the conditions in the following table are present.Reyataz ContraindicationsReyataz Novel Uses: Which Conditions Have a Clinical Trial Featuring Reyataz?
44 active trials are in progress to investigate the utility of Reyataz in treating HIV (Human Immunodeficiency Virus) and Antiretroviral Therapy in individuals of weight at least 35 kg.Reyataz Reviews: What are patients saying about Reyataz?
Patient Q&A Section about reyataz
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Is there a generic for Reyataz?
"Teva Pharmaceuticals has announced the launch of a generic version of the drug Reyataz in the United States. The drug is indicated for use in combination with other antiretroviral agents, and acts as a protease inhibitor for the treatment of HIV-1 infection in patients six years of age and older weighing at least 15 kg."
What is Reyataz used for?
"This drug is used in conjunction with other HIV medications to help control the spread of the virus. By decreasing the amount of HIV in the body, it allows the immune system to function more effectively, lowering the chances of developing complications such as new infections or cancer, and improving the patient's quality of life."
Who manufactures Reyataz?
"Teva Pharmaceuticals has announced that it will be the exclusive manufacturer of a generic version of the brand-name antiretroviral (ARV) medication Reyataz (atazanavir). Reyataz is approved for use in combination with two or more other ARVs to treat HIV."